1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global IVD Antibodies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Cardiac Markers 1.2.3 Tumor Markers 1.2.4 Kidney Injury Markers 1.3 Market by Application 1.3.1 Global IVD Antibodies Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Specialty Clinic 1.3.4 Diagnostic Center 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global IVD Antibodies Market Perspective (2016-2027) 2.2 IVD Antibodies Growth Trends by Regions 2.2.1 IVD Antibodies Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 IVD Antibodies Historic Market Share by Regions (2016-2021) 2.2.3 IVD Antibodies Forecasted Market Size by Regions (2022-2027) 2.3 IVD Antibodies Industry Dynamic 2.3.1 IVD Antibodies Market Trends 2.3.2 IVD Antibodies Market Drivers 2.3.3 IVD Antibodies Market Challenges 2.3.4 IVD Antibodies Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top IVD Antibodies Players by Revenue 3.1.1 Global Top IVD Antibodies Players by Revenue (2016-2021) 3.1.2 Global IVD Antibodies Revenue Market Share by Players (2016-2021) 3.2 Global IVD Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by IVD Antibodies Revenue 3.4 Global IVD Antibodies Market Concentration Ratio 3.4.1 Global IVD Antibodies Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by IVD Antibodies Revenue in 2020 3.5 IVD Antibodies Key Players Head office and Area Served 3.6 Key Players IVD Antibodies Product Solution and Service 3.7 Date of Enter into IVD Antibodies Market 3.8 Mergers & Acquisitions, Expansion Plans 4 IVD Antibodies Breakdown Data by Type 4.1 Global IVD Antibodies Historic Market Size by Type (2016-2021) 4.2 Global IVD Antibodies Forecasted Market Size by Type (2022-2027) 5 IVD Antibodies Breakdown Data by Application 5.1 Global IVD Antibodies Historic Market Size by Application (2016-2021) 5.2 Global IVD Antibodies Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America IVD Antibodies Market Size (2016-2027) 6.2 North America IVD Antibodies Market Size by Type 6.2.1 North America IVD Antibodies Market Size by Type (2016-2021) 6.2.2 North America IVD Antibodies Market Size by Type (2022-2027) 6.2.3 North America IVD Antibodies Market Size by Type (2016-2027) 6.3 North America IVD Antibodies Market Size by Application 6.3.1 North America IVD Antibodies Market Size by Application (2016-2021) 6.3.2 North America IVD Antibodies Market Size by Application (2022-2027) 6.3.3 North America IVD Antibodies Market Size by Application (2016-2027) 6.4 North America IVD Antibodies Market Size by Country 6.4.1 North America IVD Antibodies Market Size by Country (2016-2021) 6.4.2 North America IVD Antibodies Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe IVD Antibodies Market Size (2016-2027) 7.2 Europe IVD Antibodies Market Size by Type 7.2.1 Europe IVD Antibodies Market Size by Type (2016-2021) 7.2.2 Europe IVD Antibodies Market Size by Type (2022-2027) 7.2.3 Europe IVD Antibodies Market Size by Type (2016-2027) 7.3 Europe IVD Antibodies Market Size by Application 7.3.1 Europe IVD Antibodies Market Size by Application (2016-2021) 7.3.2 Europe IVD Antibodies Market Size by Application (2022-2027) 7.3.3 Europe IVD Antibodies Market Size by Application (2016-2027) 7.4 Europe IVD Antibodies Market Size by Country 7.4.1 Europe IVD Antibodies Market Size by Country (2016-2021) 7.4.2 Europe IVD Antibodies Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific IVD Antibodies Market Size (2016-2027) 8.2 Asia-Pacific IVD Antibodies Market Size by Type 8.2.1 Asia-Pacific IVD Antibodies Market Size by Type (2016-2021) 8.2.2 Asia-Pacific IVD Antibodies Market Size by Type (2022-2027) 8.2.3 Asia-Pacific IVD Antibodies Market Size by Type (2016-2027) 8.3 Asia-Pacific IVD Antibodies Market Size by Application 8.3.1 Asia-Pacific IVD Antibodies Market Size by Application (2016-2021) 8.3.2 Asia-Pacific IVD Antibodies Market Size by Application (2022-2027) 8.3.3 Asia-Pacific IVD Antibodies Market Size by Application (2016-2027) 8.4 Asia-Pacific IVD Antibodies Market Size by Region 8.4.1 Asia-Pacific IVD Antibodies Market Size by Region (2016-2021) 8.4.2 Asia-Pacific IVD Antibodies Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America IVD Antibodies Market Size (2016-2027) 9.2 Latin America IVD Antibodies Market Size by Type 9.2.1 Latin America IVD Antibodies Market Size by Type (2016-2021) 9.2.2 Latin America IVD Antibodies Market Size by Type (2022-2027) 9.2.3 Latin America IVD Antibodies Market Size by Type (2016-2027) 9.3 Latin America IVD Antibodies Market Size by Application 9.3.1 Latin America IVD Antibodies Market Size by Application (2016-2021) 9.3.2 Latin America IVD Antibodies Market Size by Application (2022-2027) 9.3.3 Latin America IVD Antibodies Market Size by Application (2016-2027) 9.4 Latin America IVD Antibodies Market Size by Country 9.4.1 Latin America IVD Antibodies Market Size by Country (2016-2021) 9.4.2 Latin America IVD Antibodies Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa IVD Antibodies Market Size (2016-2027) 10.2 Middle East & Africa IVD Antibodies Market Size by Type 10.2.1 Middle East & Africa IVD Antibodies Market Size by Type (2016-2021) 10.2.2 Middle East & Africa IVD Antibodies Market Size by Type (2022-2027) 10.2.3 Middle East & Africa IVD Antibodies Market Size by Type (2016-2027) 10.3 Middle East & Africa IVD Antibodies Market Size by Application 10.3.1 Middle East & Africa IVD Antibodies Market Size by Application (2016-2021) 10.3.2 Middle East & Africa IVD Antibodies Market Size by Application (2022-2027) 10.3.3 Middle East & Africa IVD Antibodies Market Size by Application (2016-2027) 10.4 Middle East & Africa IVD Antibodies Market Size by Country 10.4.1 Middle East & Africa IVD Antibodies Market Size by Country (2016-2021) 10.4.2 Middle East & Africa IVD Antibodies Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abcam 11.1.1 Abcam Company Details 11.1.2 Abcam Business Overview 11.1.3 Abcam IVD Antibodies Introduction 11.1.4 Abcam Revenue in IVD Antibodies Business (2016-2021) 11.1.5 Abcam Recent Development 11.2 Thermo Fisher Scientific 11.2.1 Thermo Fisher Scientific Company Details 11.2.2 Thermo Fisher Scientific Business Overview 11.2.3 Thermo Fisher Scientific IVD Antibodies Introduction 11.2.4 Thermo Fisher Scientific Revenue in IVD Antibodies Business (2016-2021) 11.2.5 Thermo Fisher Scientific Recent Development 11.3 Rockland Immunochemicals 11.3.1 Rockland Immunochemicals Company Details 11.3.2 Rockland Immunochemicals Business Overview 11.3.3 Rockland Immunochemicals IVD Antibodies Introduction 11.3.4 Rockland Immunochemicals Revenue in IVD Antibodies Business (2016-2021) 11.3.5 Rockland Immunochemicals Recent Development 11.4 GenScript 11.4.1 GenScript Company Details 11.4.2 GenScript Business Overview 11.4.3 GenScript IVD Antibodies Introduction 11.4.4 GenScript Revenue in IVD Antibodies Business (2016-2021) 11.4.5 GenScript Recent Development 11.5 Bio-Rad Laboratories 11.5.1 Bio-Rad Laboratories Company Details 11.5.2 Bio-Rad Laboratories Business Overview 11.5.3 Bio-Rad Laboratories IVD Antibodies Introduction 11.5.4 Bio-Rad Laboratories Revenue in IVD Antibodies Business (2016-2021) 11.5.5 Bio-Rad Laboratories Recent Development 11.6 SDIX 11.6.1 SDIX Company Details 11.6.2 SDIX Business Overview 11.6.3 SDIX IVD Antibodies Introduction 11.6.4 SDIX Revenue in IVD Antibodies Business (2016-2021) 11.6.5 SDIX Recent Development 11.7 MEDICAL & BIOLOGICAL LABORATORIES 11.7.1 MEDICAL & BIOLOGICAL LABORATORIES Company Details 11.7.2 MEDICAL & BIOLOGICAL LABORATORIES Business Overview 11.7.3 MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Introduction 11.7.4 MEDICAL & BIOLOGICAL LABORATORIES Revenue in IVD Antibodies Business (2016-2021) 11.7.5 MEDICAL & BIOLOGICAL LABORATORIES Recent Development 11.8 HyTest 11.8.1 HyTest Company Details 11.8.2 HyTest Business Overview 11.8.3 HyTest IVD Antibodies Introduction 11.8.4 HyTest Revenue in IVD Antibodies Business (2016-2021) 11.8.5 HyTest Recent Development 11.9 Abbott 11.9.1 Abbott Company Details 11.9.2 Abbott Business Overview 11.9.3 Abbott IVD Antibodies Introduction 11.9.4 Abbott Revenue in IVD Antibodies Business (2016-2021) 11.9.5 Abbott Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global IVD Antibodies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Cardiac Markers Table 3. Key Players of Tumor Markers Table 4. Key Players of Kidney Injury Markers Table 5. Global IVD Antibodies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global IVD Antibodies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global IVD Antibodies Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global IVD Antibodies Market Share by Regions (2016-2021) Table 9. Global IVD Antibodies Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global IVD Antibodies Market Share by Regions (2022-2027) Table 11. IVD Antibodies Market Trends Table 12. IVD Antibodies Market Drivers Table 13. IVD Antibodies Market Challenges Table 14. IVD Antibodies Market Restraints Table 15. Global IVD Antibodies Revenue by Players (2016-2021) & (US$ Million) Table 16. Global IVD Antibodies Market Share by Players (2016-2021) Table 17. Global Top IVD Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Antibodies as of 2020) Table 18. Ranking of Global Top IVD Antibodies Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by IVD Antibodies Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players IVD Antibodies Product Solution and Service Table 22. Date of Enter into IVD Antibodies Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global IVD Antibodies Market Size by Type (2016-2021) (US$ Million) Table 25. Global IVD Antibodies Revenue Market Share by Type (2016-2021) Table 26. Global IVD Antibodies Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global IVD Antibodies Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global IVD Antibodies Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global IVD Antibodies Revenue Market Share by Application (2016-2021) Table 30. Global IVD Antibodies Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global IVD Antibodies Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America IVD Antibodies Market Size by Type (2016-2021) (US$ Million) Table 33. North America IVD Antibodies Market Size by Type (2022-2027) & (US$ Million) Table 34. North America IVD Antibodies Market Size by Application (2016-2021) (US$ Million) Table 35. North America IVD Antibodies Market Size by Application (2022-2027) & (US$ Million) Table 36. North America IVD Antibodies Market Size by Country (2016-2021) & (US$ Million) Table 37. North America IVD Antibodies Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe IVD Antibodies Market Size by Type (2016-2021) (US$ Million) Table 39. Europe IVD Antibodies Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe IVD Antibodies Market Size by Application (2016-2021) (US$ Million) Table 41. Europe IVD Antibodies Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe IVD Antibodies Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe IVD Antibodies Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific IVD Antibodies Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific IVD Antibodies Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific IVD Antibodies Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific IVD Antibodies Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific IVD Antibodies Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific IVD Antibodies Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America IVD Antibodies Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America IVD Antibodies Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America IVD Antibodies Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America IVD Antibodies Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America IVD Antibodies Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America IVD Antibodies Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa IVD Antibodies Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa IVD Antibodies Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa IVD Antibodies Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa IVD Antibodies Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa IVD Antibodies Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa IVD Antibodies Market Size by Country (2022-2027) & (US$ Million) Table 62. Abcam Company Details Table 63. Abcam Business Overview Table 64. Abcam IVD Antibodies Product Table 65. Abcam Revenue in IVD Antibodies Business (2016-2021) & (US$ Million) Table 66. Abcam Recent Development Table 67. Thermo Fisher Scientific Company Details Table 68. Thermo Fisher Scientific Business Overview Table 69. Thermo Fisher Scientific IVD Antibodies Product Table 70. Thermo Fisher Scientific Revenue in IVD Antibodies Business (2016-2021) & (US$ Million) Table 71. Thermo Fisher Scientific Recent Development Table 72. Rockland Immunochemicals Company Details Table 73. Rockland Immunochemicals Business Overview Table 74. Rockland Immunochemicals IVD Antibodies Product Table 75. Rockland Immunochemicals Revenue in IVD Antibodies Business (2016-2021) & (US$ Million) Table 76. Rockland Immunochemicals Recent Development Table 77. GenScript Company Details Table 78. GenScript Business Overview Table 79. GenScript IVD Antibodies Product Table 80. GenScript Revenue in IVD Antibodies Business (2016-2021) & (US$ Million) Table 81. GenScript Recent Development Table 82. Bio-Rad Laboratories Company Details Table 83. Bio-Rad Laboratories Business Overview Table 84. Bio-Rad Laboratories IVD Antibodies Product Table 85. Bio-Rad Laboratories Revenue in IVD Antibodies Business (2016-2021) & (US$ Million) Table 86. Bio-Rad Laboratories Recent Development Table 87. SDIX Company Details Table 88. SDIX Business Overview Table 89. SDIX IVD Antibodies Product Table 90. SDIX Revenue in IVD Antibodies Business (2016-2021) & (US$ Million) Table 91. SDIX Recent Development Table 92. MEDICAL & BIOLOGICAL LABORATORIES Company Details Table 93. MEDICAL & BIOLOGICAL LABORATORIES Business Overview Table 94. MEDICAL & BIOLOGICAL LABORATORIES IVD Antibodies Product Table 95. MEDICAL & BIOLOGICAL LABORATORIES Revenue in IVD Antibodies Business (2016-2021) & (US$ Million) Table 96. MEDICAL & BIOLOGICAL LABORATORIES Recent Development Table 97. HyTest Company Details Table 98. HyTest Business Overview Table 99. HyTest Revenue in IVD Antibodies Business (2016-2021) & (US$ Million) Table 100. HyTest Recent Development Table 101. Abbott Company Details Table 102. Abbott Business Overview Table 103. Abbott IVD Antibodies Product Table 104. Abbott Revenue in IVD Antibodies Business (2016-2021) & (US$ Million) Table 105. Abbott Recent Development Table 106. Research Programs/Design for This Report Table 107. Key Data Information from Secondary Sources Table 108. Key Data Information from Primary Sources List of Figures Figure 1. Global IVD Antibodies Market Share by Type: 2020 VS 2027 Figure 2. Cardiac Markers Features Figure 3. Tumor Markers Features Figure 4. Kidney Injury Markers Features Figure 5. Global IVD Antibodies Market Share by Application: 2020 VS 2027 Figure 6. Hospital Case Studies Figure 7. Specialty Clinic Case Studies Figure 8. Diagnostic Center Case Studies Figure 9. Others Case Studies Figure 10. IVD Antibodies Report Years Considered Figure 11. Global IVD Antibodies Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global IVD Antibodies Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global IVD Antibodies Market Share by Regions: 2020 VS 2027 Figure 14. Global IVD Antibodies Market Share by Regions (2022-2027) Figure 15. Global IVD Antibodies Market Share by Players in 2020 Figure 16. Global Top IVD Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Antibodies as of 2020 Figure 17. The Top 10 and 5 Players Market Share by IVD Antibodies Revenue in 2020 Figure 18. Global IVD Antibodies Revenue Market Share by Type (2016-2021) Figure 19. Global IVD Antibodies Revenue Market Share by Type (2022-2027) Figure 20. North America IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America IVD Antibodies Market Share by Type (2016-2027) Figure 22. North America IVD Antibodies Market Share by Application (2016-2027) Figure 23. North America IVD Antibodies Market Share by Country (2016-2027) Figure 24. United States IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe IVD Antibodies Market Share by Type (2016-2027) Figure 28. Europe IVD Antibodies Market Share by Application (2016-2027) Figure 29. Europe IVD Antibodies Market Share by Country (2016-2027) Figure 30. Germany IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific IVD Antibodies Market Share by Type (2016-2027) Figure 38. Asia-Pacific IVD Antibodies Market Share by Application (2016-2027) Figure 39. Asia-Pacific IVD Antibodies Market Share by Region (2016-2027) Figure 40. China IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America IVD Antibodies Market Share by Type (2016-2027) Figure 48. Latin America IVD Antibodies Market Share by Application (2016-2027) Figure 49. Latin America IVD Antibodies Market Share by Country (2016-2027) Figure 50. Mexico IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa IVD Antibodies Market Share by Type (2016-2027) Figure 54. Middle East & Africa IVD Antibodies Market Share by Application (2016-2027) Figure 55. Middle East & Africa IVD Antibodies Market Share by Country (2016-2027) Figure 56. Turkey IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE IVD Antibodies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Abcam Revenue Growth Rate in IVD Antibodies Business (2016-2021) Figure 60. Thermo Fisher Scientific Revenue Growth Rate in IVD Antibodies Business (2016-2021) Figure 61. Rockland Immunochemicals Revenue Growth Rate in IVD Antibodies Business (2016-2021) Figure 62. GenScript Revenue Growth Rate in IVD Antibodies Business (2016-2021) Figure 63. Bio-Rad Laboratories Revenue Growth Rate in IVD Antibodies Business (2016-2021) Figure 64. SDIX Revenue Growth Rate in IVD Antibodies Business (2016-2021) Figure 65. MEDICAL & BIOLOGICAL LABORATORIES Revenue Growth Rate in IVD Antibodies Business (2016-2021) Figure 66. HyTest Revenue Growth Rate in IVD Antibodies Business (2016-2021) Figure 67. Abbott Revenue Growth Rate in IVD Antibodies Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Abcam Thermo Fisher Scientific Rockland Immunochemicals GenScript Bio-Rad Laboratories SDIX MEDICAL & BIOLOGICAL LABORATORIES HyTest Abbott